Questions discussed in this category
A female in her early 70s, total thyroidectomy, left 1.4 cm and right 0.7 cm tall cell variant papillary thyroid cancer with clear margins and negativ...
What is your evaluation approach for RAI response? What cumulative dose do you use in practice for deciding a patient is RAI refractory?
What techniques and doses would you prescribe to the primary and regional nodes?
Would you consider it for a patient with good PS but with limited metastatic disease? What dose fractionation would you prefer?
Patient does not have hypercalcemia.
221982156520370202841994519223803018835155218963
Papers discussed in this category
Cancer discovery, 2015-07
J Immunother Cancer,
Thyroid : official journal of the American Thyroid Association, 2020 May 07
Journal of thyroid research, 2020 Apr 14